Mpox smuggling case raises concerns over NIH oversight

Congressional officials question NIH representatives during a hearing about the agency's oversight in the Mpox smuggling case, highlighting concerns over public health and biosecurity risks.

In recent hearings, officials from the NIH faced tough questions from members of Congress about their protocols for monitoring and controlling the spread of Mpox. The hearings, held in late October 2023, highlighted potential lapses in communication and coordination among federal health agencies, which some lawmakers argue may have contributed to the smuggling issue. Furthermore, … Read more